Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer

This study has been terminated.
(Insufficient funding)
Sponsor:
Information provided by (Responsible Party):
Cortice Biosciences, Inc.
ClinicalTrials.gov Identifier:
NCT00553813
First received: November 2, 2007
Last updated: January 9, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2010
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 16, 2012